Christoph Grimm (Grimm Christoph)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 25

Top Topics

Estrogen Receptor

Endometrial Cancer

Top Venues

Journal of personalized medicine

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Arina Onoprienko, Gerda Hofstetter, Leonhard Muellauer, Tim Dorittke, Stephan Polterauer, Christoph Grimm, Thomas Bartl
Prognostic role of transcription factor ARID1A in patients with endometrial cancer of no specific molecular profile (NSMP) subtype. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (6) (2024)
Arina Onoprienko, Gerda Hofstetter, Leonhard Muellauer, Tim Dorittke, Stephan Polterauer, Christoph Grimm, Thomas Bartl
Prognostic role of transcription factor ARID1A in patients with endometrial cancer of no specific molecular profile (NSMP) subtype. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (6) (2024)
Melina Danisch, Marlene Kranawetter, Thomas Bartl, Magdalena Postl, Christoph Grimm, Eva Langthaler, Stephan Polterauer
Oncologic and Obstetric Outcomes Following Radical Abdominal Trachelectomy in Non-Low-Risk Early-Stage Cervical Cancers: A 10-Year Austrian Single-Center Experience. Journal of personalized medicine 14 (6) (2024)
Arina Onoprienko, Gerda Hofstetter, Leonhard Muellauer, Tim Dorittke, Stephan Polterauer, Christoph Grimm, Thomas Bartl
Prognostic role of transcription factor ARID1A in patients with endometrial cancer of no specific molecular profile (NSMP) subtype. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Melina Danisch, Marlene Kranawetter, Thomas Bartl, Magdalena Postl, Christoph Grimm, Eva Langthaler, Stephan Polterauer
Oncologic and Obstetric Outcomes Following Radical Abdominal Trachelectomy in Non-Low-Risk Early-Stage Cervical Cancers: A 10-Year Austrian Single-Center Experience. Journal of personalized medicine 14 (6) (2024)
Thomas Bartl, Christoph Grimm, Robert M Mader, Christoph C Zielinski, Gerald Prager, Matthias Unseld, Merima Herac-Kornauth
Interactions of EGFR/PTEN/mTOR-Pathway Activation and Estrogen Receptor Expression in Cervical Cancer. Journal of personalized medicine 13 (8) (2023)
Thomas Bartl, Anita Alberts, Sofia-Christina Papadopoulos, Andrea Wolf, Leonhard Muellauer, Gerda Hofstetter, Christoph Grimm, Dan Cacsire Castillo-Tong
Biomarkers for checkpoint inhibitor therapy in mucinous epithelial ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Thomas Bartl, Anita Alberts, Sofia-Christina Papadopoulos, Andrea Wolf, Leonhard Muellauer, Gerda Hofstetter, Christoph Grimm, Dan Cacsire Castillo-Tong
Biomarkers for checkpoint inhibitor therapy in mucinous epithelial ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Thomas Bartl, Anita Alberts, Sofia-Christina Papadopoulos, Andrea Wolf, Leonhard Muellauer, Gerda Hofstetter, Christoph Grimm, Dan Cacsire Castillo-Tong
Biomarkers for checkpoint inhibitor therapy in mucinous epithelial ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Arina Onoprienko, Gerda Hofstetter, Tim Dorittke, Christine Bekos, Christoph Grimm, Mariella Polterauer, Thomas Bartl, Stephan Polterauer
The Prognostic Value of the Fibrinogen-Albumin-Ratio Index (FARI) in Patients with Advanced Vulvar Cancer. Journal of personalized medicine 12 (11) (2022)
Richard Schwameis, Julia Ganhoer-Schimboeck, Victoria Laudia Hadjari, Lukas Hefler, Birgit Bergmeister, Tatjana Küssel, Gunda Gittler, Theodora Steindl-Schoenhuber, Christoph Grimm
TRICIN: A Phase II Trial on the Efficacy of Topical TRIchloroacetic Acid in Patients with Cervical Intraepithelial Neoplasia. Cancers 14 (23) (2022)
Elisabeth Reiser, Dietmar Pils, Christoph Grimm, Ines Hoffmann, Stephan Polterauer, Marlene Kranawetter, Stefanie Aust
Defining Models to Classify between Benign and Malignant Adnexal Masses Using Routine Laboratory Parameters. Cancers 14 (13) (2022)
Richard Schwameis, Julia Ganhoer-Schimboeck, Victoria Laudia Hadjari, Lukas Hefler, Birgit Bergmeister, Tatjana Küssel, Gunda Gittler, Theodora Steindl-Schoenhuber, Christoph Grimm
TRICIN: A Phase II Trial on the Efficacy of Topical TRIchloroacetic Acid in Patients with Cervical Intraepithelial Neoplasia. Cancers 14 (23) (2022)
Richard Schwameis, Julia Ganhoer-Schimboeck, Victoria Laudia Hadjari, Lukas Hefler, Birgit Bergmeister, Tatjana Küssel, Gunda Gittler, Theodora Steindl-Schoenhuber, Christoph Grimm
TRICIN: A Phase II Trial on the Efficacy of Topical TRIchloroacetic Acid in Patients with Cervical Intraepithelial Neoplasia. Cancers 14 (23) (2022)
Arina Onoprienko, Gerda Hofstetter, Tim Dorittke, Christine Bekos, Christoph Grimm, Mariella Polterauer, Thomas Bartl, Stephan Polterauer
The Prognostic Value of the Fibrinogen-Albumin-Ratio Index (FARI) in Patients with Advanced Vulvar Cancer. Journal of personalized medicine 12 (11) (2022)
Christina T Grech, Dietmar Pils, Stefanie Aust, Christoph Grimm, Stephan Polterauer, Alexander Reinthaller, Leonhard Müllauer, Theresa Reischer, Christine Bekos
Corrected Allele Frequency of BRCA1/2 Mutations Is an Independent Prognostic Factor for Treatment Response to PARP-Inhibitors in Ovarian Cancer Patients. Journal of personalized medicine 12 (9) (2022)
Arina Onoprienko, Gerda Hofstetter, Tim Dorittke, Christine Bekos, Christoph Grimm, Mariella Polterauer, Thomas Bartl, Stephan Polterauer
The Prognostic Value of the Fibrinogen-Albumin-Ratio Index (FARI) in Patients with Advanced Vulvar Cancer. Journal of personalized medicine 12 (11) (2022)
Christine Bekos, Christoph Grimm, Marlene Kranawetter, Stephan Polterauer, Felicitas Oberndorfer, Yen Yen Tan, Leonhard Müllauer, Christian F Singer
Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian Cancer. Journal of personalized medicine 11 (7) (2021)
Thomas Bartl, Arina Onoprienko, Gerda Hofstetter, Leonhard Müllauer, Nina Poetsch, Thorsten Fuereder, Paul Kofler, Stephan Polterauer, Christoph Grimm
Overweight as a Favorable Clinical Biomarker for Checkpoint Inhibitor Therapy Response in Recurrent Gynecologic Cancer Patients. Biomolecules 11 (11) (2021)
Felicitas Oberndorfer, Sarah Moling, Leonie Annika Hagelkruys, Christoph Grimm, Stephan Polterauer, Alina Sturdza, Stefanie Aust, Alexander Reinthaller, Leonhard Müllauer, Richard Schwameis
Risk Reclassification of Patients with Endometrial Cancer Based on Tumor Molecular Profiling: First Real World Data. Journal of personalized medicine 11 (1) (2021)
Sofie Zehentner, Agnes T Reiner, Christoph Grimm, Veronika Somoza
The Role of Bitter Taste Receptors in Cancer: A Systematic Review. Cancers 13 (23) (2021)
Thomas Bartl, Jasmine Karacs, Caroline Kreuzinger, Stephanie Pfaffinger, Jonatan Kendler, Cristina Ciocsirescu, Andrea Wolf, Alexander Reinthaller, Elias Meyer, Maximilian Brandstetter, Magdalena Postl, Eva Langthaler, Elena Braicu, Ignace Vergote, Paula Cunnea, Charlie Gourley, Wolfgang Daniel Schmitt, Dan Cacsire Castillo-Tong, Christoph Grimm
Tumor Growth Rate Estimates Are Independently Predictive of Therapy Response and Survival in Recurrent High-Grade Serous Ovarian Cancer Patients. Cancers 13 (5) (2021)
Schwameis Richard, Magdalena Postl, Christine Bekos, Lukas Hefler, Alexander Reinthaller, Veronika Seebacher, Christoph Grimm, Stephan Polterauer, Samir Helmy-Bader
Prognostic value of serum creatine level in patients with vulvar cancer. Scientific reports 9 (1) (2019)
Nina Poetsch, Alina Sturdza, Stefanie Aust, Stephan Polterauer, Christoph Grimm, Schwameis Richard, Richard Pötter, Heinz Koelbl, Reinthaller Alexander, Veronika Seebacher
The value of pretreatment serum butyrylcholinesterase level as a novel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 195 (5) (2019)
Veronika Seebacher, Stefanie Aust, David D'Andrea, Christoph Grimm, Elisabeth Reiser, Denise Tiringer, Hannah Von Mersi, Stephan Polterauer, Alexander Reinthaller, Samir Helmy-Bader
Development of a tool for prediction of ovarian cancer in patients with adnexal masses: Value of plasma fibrinogen. PloS one 12 (8) (2017)